SOPHiA GENETICS (SOPH) Depreciation & Amortization - Total (2023 - 2024)

SOPHiA GENETICS (SOPH) reported Depreciation & Amortization - Total of $1.1 million for Q4 2024, down 2.91% on a YoY basis from $1.2 million in Q1 2024, and down 2.91% sequentially from $1.2 million in Q4 2023.

SOPHiA GENETICS (SOPH) Depreciation & Amortization - Total (2023 - 2024) Analysis & Trends

SOPHiA GENETICS (SOPH) has 2 years of Depreciation & Amortization - Total data on file, last reported at $1.1 million in Q4 2024.

  • For the quarter ending Q4 2024, Depreciation & Amortization - Total fell 2.91% year-over-year to $1.1 million; the trailing twelve-month figure through Sep 2025 stood at $1.1 million (down 2.91% YoY), and the FY2024 full-year result was $4.6 million, down 24.13% from the prior year.
  • Depreciation & Amortization - Total retreated to $1.1 million in Q4 2024, from $1.2 million in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $1.2 million in Q4 2023 to a low of $1.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn -
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn -
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn -
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn -
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn -
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn -
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn -
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn -
9 Privia Health 3.10 Bn 2.73 Bn - -
10 SOPHiA GENETICS 408.62 Mn 338.33 Mn 14.69 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 1.14 Mn
Dec 31, 2023 1.17 Mn